1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Diabetes Drug Therapy Revenue 1.4 Market by Type 1.4.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Glucagon-likepeptide-1 (GLP-1)agonist 1.4.3 Dipeptidyl-peptidase-4 (DPP-4)inhibitors 1.4.4 Sodium glucoseco-transporter 2 (SGLT2)inhibitors 1.4.5 Insulin 1.4.6 Others 1.5 Market by Application 1.5.1 Global Diabetes Drug Therapy Market Share by Application: 2020 VS 2026 1.5.2 Type1 Diabetes 1.5.3 Type2 Diabetes 1.5.4 GestationalDiabetes 1.5.5 ImpairedGlucoseToleranceandImpairedFasting Glycaemia 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global Diabetes Drug Therapy Market Perspective (2015-2026) 2.2 Global Diabetes Drug Therapy Growth Trends by Regions 2.2.1 Diabetes Drug Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Diabetes Drug Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Diabetes Drug Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Diabetes Drug Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Diabetes Drug Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Diabetes Drug Therapy Players by Market Size 3.1.1 Global Top Diabetes Drug Therapy Players by Revenue (2015-2020) 3.1.2 Global Diabetes Drug Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Diabetes Drug Therapy Market Concentration Ratio 3.2.1 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Diabetes Drug Therapy Revenue in 2019 3.3 Diabetes Drug Therapy Key Players Head office and Area Served 3.4 Key Players Diabetes Drug Therapy Product Solution and Service 3.5 Date of Enter into Diabetes Drug Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Diabetes Drug Therapy Historic Market Size by Type (2015-2020) 4.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global Diabetes Drug Therapy Market Size by Application (2015-2020) 5.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Diabetes Drug Therapy Market Size (2015-2020) 6.2 Diabetes Drug Therapy Key Players in North America (2019-2020) 6.3 North America Diabetes Drug Therapy Market Size by Type (2015-2020) 6.4 North America Diabetes Drug Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Diabetes Drug Therapy Market Size (2015-2020) 7.2 Diabetes Drug Therapy Key Players in Europe (2019-2020) 7.3 Europe Diabetes Drug Therapy Market Size by Type (2015-2020) 7.4 Europe Diabetes Drug Therapy Market Size by Application (2015-2020) 8 China 8.1 China Diabetes Drug Therapy Market Size (2015-2020) 8.2 Diabetes Drug Therapy Key Players in China (2019-2020) 8.3 China Diabetes Drug Therapy Market Size by Type (2015-2020) 8.4 China Diabetes Drug Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Diabetes Drug Therapy Market Size (2015-2020) 9.2 Diabetes Drug Therapy Key Players in Japan (2019-2020) 9.3 Japan Diabetes Drug Therapy Market Size by Type (2015-2020) 9.4 Japan Diabetes Drug Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Diabetes Drug Therapy Market Size (2015-2020) 10.2 Diabetes Drug Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Diabetes Drug Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Diabetes Drug Therapy Market Size by Application (2015-2020) 11 India 11.1 India Diabetes Drug Therapy Market Size (2015-2020) 11.2 Diabetes Drug Therapy Key Players in India (2019-2020) 11.3 India Diabetes Drug Therapy Market Size by Type (2015-2020) 11.4 India Diabetes Drug Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Diabetes Drug Therapy Market Size (2015-2020) 12.2 Diabetes Drug Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Diabetes Drug Therapy Market Size by Type (2015-2020) 12.4 Central & South America Diabetes Drug Therapy Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Abbott Laboratories 13.1.1 Abbott Laboratories Company Details 13.1.2 Abbott Laboratories Business Overview 13.1.3 Abbott Laboratories Diabetes Drug Therapy Introduction 13.1.4 Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2015-2020)) 13.1.5 Abbott Laboratories Recent Development 13.2 Mannkind Corporation 13.2.1 Mannkind Corporation Company Details 13.2.2 Mannkind Corporation Business Overview 13.2.3 Mannkind Corporation Diabetes Drug Therapy Introduction 13.2.4 Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2015-2020) 13.2.5 Mannkind Corporation Recent Development 13.3 Bristol Myers Squibb 13.3.1 Bristol Myers Squibb Company Details 13.3.2 Bristol Myers Squibb Business Overview 13.3.3 Bristol Myers Squibb Diabetes Drug Therapy Introduction 13.3.4 Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2015-2020) 13.3.5 Bristol Myers Squibb Recent Development 13.4 Medtronic 13.4.1 Medtronic Company Details 13.4.2 Medtronic Business Overview 13.4.3 Medtronic Diabetes Drug Therapy Introduction 13.4.4 Medtronic Revenue in Diabetes Drug Therapy Business (2015-2020) 13.4.5 Medtronic Recent Development 13.5 AstraZeneca 13.5.1 AstraZeneca Company Details 13.5.2 AstraZeneca Business Overview 13.5.3 AstraZeneca Diabetes Drug Therapy Introduction 13.5.4 AstraZeneca Revenue in Diabetes Drug Therapy Business (2015-2020) 13.5.5 AstraZeneca Recent Development 13.6 Eli Lilly and Company 13.6.1 Eli Lilly and Company Company Details 13.6.2 Eli Lilly and Company Business Overview 13.6.3 Eli Lilly and Company Diabetes Drug Therapy Introduction 13.6.4 Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2015-2020) 13.6.5 Eli Lilly and Company Recent Development 13.7 GlaxoSmithKline 13.7.1 GlaxoSmithKline Company Details 13.7.2 GlaxoSmithKline Business Overview 13.7.3 GlaxoSmithKline Diabetes Drug Therapy Introduction 13.7.4 GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2015-2020) 13.7.5 GlaxoSmithKline Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview 13.8.3 Sanofi Diabetes Drug Therapy Introduction 13.8.4 Sanofi Revenue in Diabetes Drug Therapy Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 Novo Nordisk 13.9.1 Novo Nordisk Company Details 13.9.2 Novo Nordisk Business Overview 13.9.3 Novo Nordisk Diabetes Drug Therapy Introduction 13.9.4 Novo Nordisk Revenue in Diabetes Drug Therapy Business (2015-2020) 13.9.5 Novo Nordisk Recent Development 13.10 Novartis International AG 13.10.1 Novartis International AG Company Details 13.10.2 Novartis International AG Business Overview 13.10.3 Novartis International AG Diabetes Drug Therapy Introduction 13.10.4 Novartis International AG Revenue in Diabetes Drug Therapy Business (2015-2020) 13.10.5 Novartis International AG Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Diabetes Drug Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Diabetes Drug Therapy Revenue Table 3. Ranking of Global Top Diabetes Drug Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Diabetes Drug Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Glucagon-likepeptide-1 (GLP-1)agonist Table 6. Key Players of Dipeptidyl-peptidase-4 (DPP-4)inhibitors Table 7. Key Players of Sodium glucoseco-transporter 2 (SGLT2)inhibitors Table 8. Key Players of Insulin Table 9. Key Players of Others Table 10. Global Diabetes Drug Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Diabetes Drug Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Diabetes Drug Therapy Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Diabetes Drug Therapy Market Share by Regions (2015-2020) Table 14. Global Diabetes Drug Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Diabetes Drug Therapy Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Diabetes Drug Therapy Market Growth Strategy Table 20. Main Points Interviewed from Key Diabetes Drug Therapy Players Table 21. Global Diabetes Drug Therapy Revenue by Players (2015-2020) (Million US$) Table 22. Global Diabetes Drug Therapy Market Share by Players (2015-2020) Table 23. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drug Therapy as of 2019) Table 24. Global Diabetes Drug Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Diabetes Drug Therapy Product Solution and Service Table 27. Date of Enter into Diabetes Drug Therapy Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 30. Global Diabetes Drug Therapy Market Size Share by Type (2015-2020) Table 31. Global Diabetes Drug Therapy Revenue Market Share by Type (2021-2026) Table 32. Global Diabetes Drug Therapy Market Size Share by Application (2015-2020) Table 33. Global Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 34. Global Diabetes Drug Therapy Market Size Share by Application (2021-2026) Table 35. North America Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 36. North America Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 37. North America Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 38. North America Diabetes Drug Therapy Market Share by Type (2015-2020) Table 39. North America Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 40. North America Diabetes Drug Therapy Market Share by Application (2015-2020) Table 41. Europe Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 43. Europe Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 44. Europe Diabetes Drug Therapy Market Share by Type (2015-2020) Table 45. Europe Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 46. Europe Diabetes Drug Therapy Market Share by Application (2015-2020) Table 47. China Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 48. China Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 49. China Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 50. China Diabetes Drug Therapy Market Share by Type (2015-2020) Table 51. China Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 52. China Diabetes Drug Therapy Market Share by Application (2015-2020) Table 53. Japan Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 55. Japan Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 56. Japan Diabetes Drug Therapy Market Share by Type (2015-2020) Table 57. Japan Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 58. Japan Diabetes Drug Therapy Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 61. Southeast Asia Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Diabetes Drug Therapy Market Share by Type (2015-2020) Table 63. Southeast Asia Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Diabetes Drug Therapy Market Share by Application (2015-2020) Table 65. India Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 66. India Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 67. India Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 68. India Diabetes Drug Therapy Market Share by Type (2015-2020) Table 69. India Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 70. India Diabetes Drug Therapy Market Share by Application (2015-2020) Table 71. Central & South America Key Players Diabetes Drug Therapy Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Diabetes Drug Therapy Market Share (2019-2020) Table 73. Central & South America Diabetes Drug Therapy Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Diabetes Drug Therapy Market Share by Type (2015-2020) Table 75. Central & South America Diabetes Drug Therapy Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Diabetes Drug Therapy Market Share by Application (2015-2020) Table 77. Abbott Laboratories Company Details Table 78. Abbott Laboratories Business Overview Table 79. Abbott Laboratories Product Table 80. Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 81. Abbott Laboratories Recent Development Table 82. Mannkind Corporation Company Details Table 83. Mannkind Corporation Business Overview Table 84. Mannkind Corporation Product Table 85. Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 86. Mannkind Corporation Recent Development Table 87. Bristol Myers Squibb Company Details Table 88. Bristol Myers Squibb Business Overview Table 89. Bristol Myers Squibb Product Table 90. Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 91. Bristol Myers Squibb Recent Development Table 92. Medtronic Company Details Table 93. Medtronic Business Overview Table 94. Medtronic Product Table 95. Medtronic Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 96. Medtronic Recent Development Table 97. AstraZeneca Company Details Table 98. AstraZeneca Business Overview Table 99. AstraZeneca Product Table 100. AstraZeneca Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 101. AstraZeneca Recent Development Table 102. Eli Lilly and Company Company Details Table 103. Eli Lilly and Company Business Overview Table 104. Eli Lilly and Company Product Table 105. Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 106. Eli Lilly and Company Recent Development Table 107. GlaxoSmithKline Company Details Table 108. GlaxoSmithKline Business Overview Table 109. GlaxoSmithKline Product Table 110. GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 111. GlaxoSmithKline Recent Development Table 112. Sanofi Business Overview Table 113. Sanofi Product Table 114. Sanofi Company Details Table 115. Sanofi Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 116. Sanofi Recent Development Table 117. Novo Nordisk Company Details Table 118. Novo Nordisk Business Overview Table 119. Novo Nordisk Product Table 120. Novo Nordisk Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 121. Novo Nordisk Recent Development Table 122. Novartis International AG Company Details Table 123. Novartis International AG Business Overview Table 124. Novartis International AG Product Table 125. Novartis International AG Revenue in Diabetes Drug Therapy Business (2015-2020) (Million US$) Table 126. Novartis International AG Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Diabetes Drug Therapy Market Share by Type: 2020 VS 2026 Figure 2. Glucagon-likepeptide-1 (GLP-1)agonist Features Figure 3. Dipeptidyl-peptidase-4 (DPP-4)inhibitors Features Figure 4. Sodium glucoseco-transporter 2 (SGLT2)inhibitors Features Figure 5. Insulin Features Figure 6. Others Features Figure 7. Global Diabetes Drug Therapy Market Share by Application: 2020 VS 2026 Figure 8. Type1 Diabetes Case Studies Figure 9. Type2 Diabetes Case Studies Figure 10. GestationalDiabetes Case Studies Figure 11. ImpairedGlucoseToleranceandImpairedFasting Glycaemia Case Studies Figure 12. Diabetes Drug Therapy Report Years Considered Figure 13. Global Diabetes Drug Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Diabetes Drug Therapy Market Share by Regions: 2020 VS 2026 Figure 15. Global Diabetes Drug Therapy Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Diabetes Drug Therapy Market Share by Players in 2019 Figure 18. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Drug Therapy as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Diabetes Drug Therapy Revenue in 2019 Figure 20. North America Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. China Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Japan Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Southeast Asia Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 25. India Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Central & South America Diabetes Drug Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Bottom-up and Top-down Approaches for This Report Figure 28. Data Triangulation Figure 29. Key Executives Interviewed

Abbott Laboratories Mannkind Corporation Bristol Myers Squibb Medtronic AstraZeneca Eli Lilly and Company GlaxoSmithKline Sanofi Novo Nordisk Novartis International AG